Our Portfolio
When a company comes into Bridgewest Ventures they become part of a family. We are 100% committed to seeing them succeed, and each of our companies gets access to the wealth of expertise and resources we have available throughout the wider Bridgewest Group.
Select a company below, or scroll down, to learn more.
PARTNERSHIP FORMED: DECEMBER 2020
Using an Artificial Intelligence based test automation platform, The TestMart makes it easy to create and maintain fully automated tests either from scratch, or using pre-tested templates. They specialise in SaaS ERP Automated testing and release management.
PARTNERSHIP FORMED: APRIL 2021
MACSO automates the power of artificial intelligence, so training and building algorithms for AI devices is simpler. Their AI Sensor Solutions (AISS) applies expert data science to the information sets you collect, making sense of data like never before.
PARTNERSHIP FORMED: JULY 2021
BioOra is revolutionising cancer immunotherapy by automating and scaling the production of Chimeric Antigen Receptor T (CAR T)-cells, to deliver this life-saving technology at a fraction of standard costs and time.
PARTNERSHIP FORMED: SEPTEMBER 2021
PHYTRAC provides a dynamic data-driven platform to revolutionise the global implementation & monitoring of phyto-systems that restore, regenerate & reclaim contaminated earth.
PARTNERSHIP FORMED: NOVEMBER 2021
Precision Chroma have developed 3D Printed Monolith Adsorption (PMA) columns with optimised fluidics to transform chromatography processes for efficient and cost-effective purification of biological therapeutics.
PARTNERSHIP FORMED: FEBRUARY 2022
Nanophage Technologies are using biological nanorod technology to develop diagnostic tools. These tools identify molecules of interest at biologically relevant concentrations for fast, accurate and early diagnosis.
PARTNERSHIP FORMED: MARCH 2022
Avasa are developing advanced medical solutions in the field of reconstructive surgery. Their patented Arterial Coupler is helping surgeons reconnect microvascular arteries simply and efficiently in tissue transfer and transplant surgery.
PARTNERSHIP FORMED: MARCH 2022
BioViros is a a New Zealand-based lentivirus manufacturer offering affordable, customised viral vectors for cell and gene therapy with world class quality.
PARTNERSHIP FORMED: MARCH 2022
TheiaNova is developing a unique, non-invasive therapy which will induce therapeutic remodeling of the cornea in patients with ectatic disorders such as keratoconus.
PARTNERSHIP FORMED: MARCH 2022
BioValeo provides personalised, Contract Research Organisation for clinical trials, specialising in CAR T-cell therapy, personalised medicines, and immunology-based treatments.
PARTNERSHIP FORMED: NOVEMBER 2023
DORIS - Dynamic Oncology Reference Information System. Leveraging cutting-edge technology to transform cancer care with fast, accurate, and up-to-date oncology information for doctors and patients.
PARTNERSHIP FORMED: JANUARY 2024
ZealaFoam tackles the EPS plastic waste crisis with E-PLA, a fully biobased alternative. Revolutionizing packaging, ZealaFoam's innovative solution offers sustainability in a $30 billion market.
PARTNERSHIP FORMED: FEBRUARY 2024
Luminoma is pioneering a non-invasive skin cancer screening tool. By detecting molecular changes in cells, Luminoma delivers rapid and accurate diagnosis, reducing patient stress and healthcare system burden.
Apply today!
Have you got the next big idea in deep tech? Apply today!